title: Conceptualizing a tool to optimize therapy based on dynamic heterogeneity.
abstract: Complex biological systems often display a randomness paralleled in processes studied in fundamental physics. This simple stochasticity emerges owing to the complexity of the system and underlies a fundamental aspect of biology called phenotypic stochasticity. Ongoing stochastic fluctuations in phenotype at the single-unit level can contribute to two emergent population phenotypes. Phenotypic stochasticity not only generates heterogeneity within a cell population, but also allows reversible transitions back and forth between multiple states. This phenotypic interconversion tends to restore a population to a previous composition after that population has been depleted of specific members. We call this tendency homeostatic heterogeneity. These concepts of dynamic heterogeneity can be applied to populations composed of molecules, cells, individuals, etc. Here we discuss the concept that phenotypic stochasticity both underlies the generation of heterogeneity within a cell population and can be used to control population composition, contributing, in particular, to both the ongoing emergence of drug resistance and an opportunity for depleting drug-resistant cells. Using notions of both 'large' and 'small' numbers of biomolecular components, we rationalize our use of Markov processes to model the generation and eradication of drug-resistant cells. Using these insights, we have developed a graphical tool, called a metronomogram, that we propose will allow us to optimize dosing frequencies and total course durations for clinical benefit.
authors.affiliation: Department of Pathology, University of California, San Francisco, San Francisco, CA 94143, USA. David.Liao@ucsf.edu
authors.forename: David
authors.initials: D
authors.lastname: Liao
authors.forename: Luis
authors.initials: L
authors.lastname: Estévez-Salmerón
authors.forename: Thea D
authors.initials: TD
authors.lastname: Tlsty
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D019008:Drug Resistance, Neoplasm; D018628:Gene Dosage; D006801:Humans; D008390:Markov Chains; D008954:Models, Biological; D009369:Neoplasms / Q000188:drug therapy* / Q000235:genetics*; D010641:Phenotype; D013269:Stochastic Processes
chemical_list: D000970:Antineoplastic Agents